Abstract:RATIONALE:Endothelial dysfunction results in sustained and chronic vascular inflammation, which is central to atherosclerotic diseases. However, transcriptional regulation of vascular endothelial inflammation has not been well clarified.OBJECTIVE:This study aims to explore Foxp (forkhead box P) transcription factor 1 in regulation of endothelial homeostasis, atherogenesis, and its mechanisms.METHODS AND RESULTS:To assess the importance of Foxp1 in atherosclerosis, Foxp1 expression was analyzed in human coronary artery and mouse artery, and we observed significant downregulation of Foxp1 in atherosclerotic and atherosusceptible endothelium. Endothelial-specific Foxp1 knockout mice (Foxp1ECKO) were bred onto ApoeKO mice to generate endothelial Foxp1-deletion hyperlipidemic model Foxp1ECKO;ApoeKO, which displayed significant increases in atherosclerotic lesion formation in aortas and aortic roots with enhanced monocyte adhesion, migration, and infiltration into the vascular wall and formation of inflammatory lipid-laden macrophages. In contrast, endothelial-specific Foxp1 overexpression mice Foxp1ECTg;ApoeKO exhibited reduced atherosclerotic lesion formation with less monocyte infiltration. Foxp1 was further identified as a gatekeeper of vessel inflammation by direct regulation of endothelial inflammasome components, including Nlrp3 (NLR [nucleotide-binding and leucine-rich repeat immune receptors] family pyrin domain containing 3), caspase-1, and IL (interleukin)-1β. Moreover, endothelial Foxp1 was found to be regulated by Klf2 (Kruppel-like factor 2). Oscillatory shear stress downregulated Foxp1 expression via repressing Klf2 expression in endothelium, and, therefore, promoted endothelial inflammasome activation, leading to atherosclerotic lesion formation. Simvastatin upregulated the reduced expression of Klf2 and Foxp1 in atherosusceptible vascular endothelium and alleviated vascular inflammation contributing to its inhibitory effect in atherosclerosis.CONCLUSIONS:These data are the first in vivo experimental validation of an atheroprotective role of endothelial Klf2 and Foxp1, which reveals a Klf2-Foxp1 transcriptional network in endothelial cells as a novel regulator of endothelial inflammasome activation for atherogenesis, therefore, provides opportunities for therapeutic intervention of atherosclerotic diseases and uncovers a novel atheroprotective mechanism for simvastatin.

Krüppel-like Factor 14, a Coronary Artery Disease Associated Transcription Factor, Inhibits Endothelial Inflammation Via NF-κB Signaling Pathway.

GW28-e1003 Krüppel-like Factor 14, a Coronary Artery Disease Associated Transcription Factor, Inhibits Endothelial Inflammation Via NF-κB Signaling Pathway

Fn14 is regulated via the RhoA pathway and mediates nuclear factor-kappaB activation by Angiotensin II.

Endothelial Foxp1 Suppresses Atherosclerosis Via Modulation of Nlrp3 Inflammasome Activation.

Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice.

Transactivation Domain of Krüppel‐like Factor 15 Negatively Regulates Angiotensin II–induced Adventitial Inflammation and Fibrosis

Kruppel Like Factor 15 Attenuates Activation Of Adventitial Fibroblasts-Mediated Angiotensin Ii-Induced Vascular Remodeling

KLF11 (Krüppel-Like Factor 11) Inhibits Arterial Thrombosis Via Suppression of Tissue Factor in the Vascular Wall

Abstract 265: Endothelial Krüppel Like Factor 11 Inhibits Abdominal Aortic Aneurysm

Krüppel-Like Factor 15 Modulates CXCL1/CXCR2 Signaling-Mediated Inflammatory Response Contributing to Angiotensin II-Induced Cardiac Remodeling

Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2*

Krüppel-like transcription factor 14 alleviates alveolar epithelial cell senescence by inhibiting endoplasmic reticulum stress in pulmonaryfibrosis

Role of Kruppel-like factor 4 in atherosclerosis

Intestinal epithelial Krüppel-like factor 4 alleviates endotoxemia and atherosclerosis through improving NF-κB/miR-34a-mediated intestinal permeability

Hemizygous Deficiency of Krüppel-Like Factor 2 Augments Experimental Atherosclerosis

KLF11 Protects Against Abdominal Aortic Aneurysm Through Inhibition of Endothelial Cell Dysfunction.

The Kruppel-Like Factor Klf15 Inhibits Connective Tissue Growth Factor (Ctgf) Expression In Cardiac Fibroblasts.

TRIM14 Promotes Endothelial Activation Via Activating NF-κB Signaling Pathway

The transcription factor KLF14 attenuates LPS-induced acute lung injury by ameliorating apoptosis of alveolar epithelial cells in mice

Hemizygous Deficiency Of Kruppel-Like Factor 2 Augments Experimental Atherosclerosis

Histone Deacetylase 5 Interacts with Krüppel-like Factor 2 and Inhibits Its Transcriptional Activity in Endothelium.